Tvardi Therapeutics (TVRD) Assets Average (2016 - 2025)
Tvardi Therapeutics' Assets Average history spans 12 years, with the latest figure at $35.5 million for Q4 2025.
- On a quarterly basis, Assets Average fell 17.84% to $35.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $35.5 million, a 17.84% decrease, with the full-year FY2025 number at $33.6 million, down 58.23% from a year prior.
- Assets Average hit $35.5 million in Q4 2025 for Tvardi Therapeutics, down from $41.4 million in the prior quarter.
- Over the last five years, Assets Average for TVRD hit a ceiling of $260.7 million in Q1 2021 and a floor of $35.5 million in Q4 2025.
- Historically, Assets Average has averaged $142.1 million across 5 years, with a median of $134.3 million in 2023.
- Biggest five-year swings in Assets Average: surged 41.42% in 2021 and later crashed 65.66% in 2025.
- Tracing TVRD's Assets Average over 5 years: stood at $236.1 million in 2021, then dropped by 16.18% to $197.9 million in 2022, then plummeted by 39.06% to $120.6 million in 2023, then crashed by 64.12% to $43.3 million in 2024, then fell by 17.84% to $35.5 million in 2025.
- Business Quant data shows Assets Average for TVRD at $35.5 million in Q4 2025, $41.4 million in Q3 2025, and $41.3 million in Q2 2025.